|
|
The concept of Diabetes & CV risk: A lifetime risk challenge
|
|
|
|
New ESC/EASD Guidelines
|
|
|
|
Ten important recommendations (1)
|
|
|
|
Ten important recommendations (2)
|
|
|
|
Euro Heart Survey Diabetes and the Heart
Participating centres
|
|
|
|
Glycemic control
Experiences from the Euro Heart Survey
Glucose lowering drugs at follow up in patients with newly detected diabetes
|
|
|
|
Euro Heart Survey Diabetes and the Heart Newly detected diabetes: Combined cardiovascular events with or without prescribed pharmacological glucose-lowering treatment
|
|
|
|
Euro Heart Survey Diabetes and the Heart OGTT outcome
|
|
|
|
Euro Heart Survey Diabetes and the Heart Fasting and post-load glycaemia in patients with CAD and without previously diagnosed diabetes
|
|
|
|
Hyperglycaemia is common and often undiagnosed in patients with CAD in Europe and Asia
|
|
|
|
Undiagnosed diabetes in the U.S. population aged ≥ 20 years by diagnostic criteria
|
|
|
|
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes
|
|
|
|
Type 2 Diabetes: some evidence based recommendations in primary CV prevention 2011
|
|
|
|
Multifactorial Intervention in type 2 Diabetes
Euro Heart Survey Diabetes and the Heart
|
|
|
|
Multifactorial Intervention in type 2 Diabetes
Euro Heart Survey Diabetes and the Heart
|
|
Diabetes and Cv risk Routine practice versus guidelines prof Standl (PPTX 1.7MB)
Share this page with your colleagues and friends: